CEBP Prevention Award Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horn-Ross, P. L.
Right arrow Articles by Krone, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horn-Ross, P. L.
Right arrow Articles by Krone, M. R.
Cancer Epidemiology Biomarkers & Prevention Vol. 10, 979-985, September 2001
© 2001 American Association for Cancer Research

Iodine and Thyroid Cancer Risk among Women in a Multiethnic Population

The Bay Area Thyroid Cancer Study1

Pamela L. Horn-Ross2, J. Steven Morris, Marion Lee, Dee W. West, Alice S. Whittemore, I. Ross McDougall, Kent Nowels, Susan L. Stewart, Vickie L. Spate, Amy C. Shiau and Melissa R. Krone

Northern California Cancer Center, Union City, California 94587 [P. L. H-R., M. L., D. W. W., A. S. W., S. L. S., A. C. S., M. R. K.]; Research Reactor Facility, University of Missouri, Columbia, Missouri 65211 [J. S. M., V. L. S.]; Department of Epidemiology and Biostatistics, University of California School of Medicine, San Francisco, California 94143 [M. L.]; and Departments of Health Research and Policy [A. S. W.], Radiology and Medicine [I. R. M.], and Pathology [K. N.], Stanford University School of Medicine, Palo Alto, California 94305

Research on the relationship between iodine exposure and thyroid cancer risk is limited, and the findings are inconclusive. In most studies, fish/shellfish consumption has been used as a proxy measure of iodine exposure. The present study extends this research by quantifying dietary iodine exposure as well as incorporating a biomarker of long-term (1 year) exposure, i.e., from toenail clippings. This study is conducted in a multiethnic population with a wide variation in thyroid cancer incidence rates and substantial diversity in exposure. Women, ages 20–74, residing in the San Francisco Bay Area and diagnosed with thyroid cancer between 1995 and 1998 (1992–1998 for Asian women) were compared with women selected from the general population via random digit dialing. Interviews were conducted in six languages with 608 cases and 558 controls. The established risk factors for thyroid cancer were found to increase risk in this population: radiation to the head/neck [odds ratio (OR), 2.3; 95% confidence interval (CI), 0.97–5.5]; history of goiter/nodules (OR, 3.7; 95% CI, 2.5–5.6); and a family history of proliferative thyroid disease (OR, 2.5; 95% CI, 1.6–3.8). Contrary to our hypothesis, increased dietary iodine, most likely related to the use of multivitamin pills, was associated with a reduced risk of papillary thyroid cancer. This risk reduction was observed in "low-risk" women (i.e., women without any of the three established risk factors noted above; OR, 0.53; 95% CI, 0.33–0.85) but not in "high-risk" women, among whom a slight elevation in risk was seen (OR, 1.4; 95% CI, 0.56–3.4). However, no association with risk was observed in either group when the biomarker of exposure was evaluated. In addition, no ethnic differences in risk were observed. The authors conclude that iodine exposure appears to have, at most, a weak effect on the risk of papillary thyroid cancer.




This article has been cited by other articles:


Home page
JNMHome page
E. S. Mittra, R. D. Niederkohr, C. Rodriguez, T. El-Maghraby, and I. R. McDougall
Uncommon Causes of Thyrotoxicosis
J. Nucl. Med., February 1, 2008; 49(2): 265 - 278.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. J. Canchola, P. L. Horn-Ross, and D. M. Purdie
Risk of Second Primary Malignancies in Women with Papillary Thyroid Cancer
Am. J. Epidemiol., March 15, 2006; 163(6): 521 - 527.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. Haselkorn, S. L. Stewart, and P. L. Horn-Ross
Why Are Thyroid Cancer Rates So High in Southeast Asian Women Living in the United States? The Bay Area Thyroid Cancer Study
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 144 - 150.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. L. Horn-Ross, K. J. Hoggatt, and M. M. Lee
Phytoestrogens and Thyroid Cancer Risk: The San Francisco Bay Area Thyroid Cancer Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 43 - 49.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. C. Sakoda and P. L. Horn-Ross
Reproductive and Menstrual History and Papillary Thyroid Cancer Risk: The San Francisco Bay Area Thyroid Cancer Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 51 - 57.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.